Search research articles
Contact Us
Filters
Showing results (21-30 of 429) with videos related to
Page
of 43
Sort By:
The Journal of Reproductive Medicine
|
July 30, 2005
Update on the management of ovarian germ cell tumors
Karen H Lu, David M Gershenson
Gynecologic Oncology
|
August 30, 2016
Conundrums in the management of malignant ovarian germ cell tumors: Toward lessening acute morbidity and late effects of treatment
David M Gershenson, A Lindsay Frazier
Current Oncology Reports
|
October 22, 2008
Low-grade serous ovarian cancer: a unique disease
Kathleen M Schmeler, David M Gershenson
Hematology/Oncology Clinics of North America
|
November 5, 2018
Treatment of Rare Epithelial Ovarian Tumors
Lauren P Cobb, David M Gershenson
Gynecologic Oncology
|
April 1, 1989
Secondary cytoreductive surgery in epithelial ovarian cancer: nonresponders to first-line therapy
M Morris, D M Gershenson, J T Wharton
Cancer
|
January 1, 1992
Mucinous carcinoma of the ovary. Pathologic prognostic factors
W Watkin, E G Silva, D M Gershenson
Gynecologic Oncology Reports
|
November 18, 2020
Response to re-challenge of a MEK inhibitor in a patient with recurrent low-grade serous carcinoma of the peritoneum
David M Gershenson, Priya Bhosale, Rachel N Grisham
Cancer
|
January 1, 1989
Sexual dysfunction and treatment for early stage cervical cancer
L R Schover, M Fife, D M Gershenson
Archives of Pathology & Laboratory Medicine
|
September 1, 1987
Squamous cell carcinoma of the ovary
B Tetu, E G Silva, D M Gershenson
Cancer
|
May 1, 1985
Mucinous tumors of the ovary. A clinicopathologic study of 70 cases
B A Chaitin, D M Gershenson, H L Evans
Page
of 43
Search research articles
Search
Showing results (21-30 of 429) with videos related to
Sort By:
Page
of 43
The Journal of Reproductive Medicine
|
July 30, 2005
Update on the management of ovarian germ cell tumors
Karen H Lu, David M Gershenson
Gynecologic Oncology
|
August 30, 2016
Conundrums in the management of malignant ovarian germ cell tumors: Toward lessening acute morbidity and late effects of treatment
David M Gershenson, A Lindsay Frazier
Current Oncology Reports
|
October 22, 2008
Low-grade serous ovarian cancer: a unique disease
Kathleen M Schmeler, David M Gershenson
Hematology/Oncology Clinics of North America
|
November 5, 2018
Treatment of Rare Epithelial Ovarian Tumors
Lauren P Cobb, David M Gershenson
Gynecologic Oncology
|
April 1, 1989
Secondary cytoreductive surgery in epithelial ovarian cancer: nonresponders to first-line therapy
M Morris, D M Gershenson, J T Wharton
Cancer
|
January 1, 1992
Mucinous carcinoma of the ovary. Pathologic prognostic factors
W Watkin, E G Silva, D M Gershenson
Gynecologic Oncology Reports
|
November 18, 2020
Response to re-challenge of a MEK inhibitor in a patient with recurrent low-grade serous carcinoma of the peritoneum
David M Gershenson, Priya Bhosale, Rachel N Grisham
Cancer
|
January 1, 1989
Sexual dysfunction and treatment for early stage cervical cancer
L R Schover, M Fife, D M Gershenson
Archives of Pathology & Laboratory Medicine
|
September 1, 1987
Squamous cell carcinoma of the ovary
B Tetu, E G Silva, D M Gershenson
Cancer
|
May 1, 1985
Mucinous tumors of the ovary. A clinicopathologic study of 70 cases
B A Chaitin, D M Gershenson, H L Evans
Page
of 43